On October 03, 2023, the Biden administration announced indictments and sanctions against 28 individuals and entities, including China-based companies and their employees related to the trafficking of chemicals needed for the manufacturing of fentanyl. The sanctions aim to interrupt the global supply chain of fentanyl as the administration have increased their efforts on tackling the opioid epidemic. However, rising tensions in the U.S.-China relationship have delayed progress. On September 15, 2023, President Biden added China to the list of the world’s major illicit drug producing and drug transit countries. In response, China’s Ministry of Foreign Affairs stated that the designation is a malicious smear against China. The Ministry further urged the U.S. to do things in ways that are conducive to cooperation with China, not otherwise. With growing international tensions and an epidemic still afoot, the U.S. faces a challenging uphill battle with fentanyl.
As marijuana use has been legalized in some capacity in a majority of states, there remains a notable population who is still banned from its use: student athletes. However, recent recommendations to the National Collegiate Athletic Association (NCAA) means that change could be on the horizon for collegiate athletes. Earlier this summer, the NCAA Committee on Competitive Safeguards and Medical Aspects of Sports (CSMAS) signaled its support for removing cannabis from the banned substance list and drug-testing protocols for student athletes. On September 22, 2023 the committee officially recommended that all three NCAA divisional bodies adopt legislation to remove cannabinoids from the banned drug classes. The recommendation was based upon the conclusion at the Summit on Cannabinoids in College Athletics hosted by the NCAA last December. They concluded that cannabinoids are not considered to be performance-enhancing, and the current policy was found to be ineffective at prohibiting use, and better implemented by individual schools.
Lab-grown meat, also known as cultured or cell-based meat, is recognized as a revolutionary innovation in the food industry. Lab-grown meat has garnered significant attention and investment because it offers a more sustainable alternative to traditional livestock farming. However, behind the promise of this cutting-edge technology lies a complex web of regulatory and compliance challenges that must be addressed to ensure its successful integration into the market.
In 2020, many millennials turned to YouTube to watch what we thought would be a behind-the-scenes look into the life of Paris Hilton. What we didn’t expect was to learn that, just like thousands of teenagers across this country, Paris endured trauma while living in a “troubled teen” home. Since then, along with Congress, Paris has lobbied to enact laws to regulate the troubled youth facilities as it uses loopholes to get around what some would consider to be cruel punishment against kids.
Under the Safe Drinking Water Act, the Environmental Protection Agency (EPA) has the authority to regulate drinking water contaminants and require monitoring of public water systems. On March 14, 2023, the EPA announced the proposed National Primary Drinking Water Regulation (NPDWR) for a new federal standard to regulate PFAS in drinking water. PFAS are synthetic chemicals that can repel oil, water, and stains, which makes them useful for many products and industries. While there are currently state laws regulating PFAS in drinking water, the federal rule would be a huge step towards reducing exposure to these “forever chemicals” and preventing harm to public health.
Welcome back! Part One of this two-part series discussed the regulatory background of private funds and the increasing importance of private funds industry regulation today, particularly for retired and retiring Americans. Part Two of the series takes a closer look at the final new rules implemented by Securities and Exchange Commission (SEC) Chair Gary Gensler. The Chair released the new rules in August affecting private funds advisors and investors. This article also discusses Wall Street’s response to the new regulations and ends with its possible implications for the industry.
With the recent death of trailblazing Congresswoman Diane Feinstein, discussion of whether Congress members, and politicians in general, should be allowed to serve long after the retirement age are becoming even more prevalent. This conversation is important as people who hold opposite opinions have valid arguments that must be considered. On one hand, the United States has banned age discrimination in the workplace. On the other hand, keeping people who have declining physical or cognitive health may pose a safety concern for our nation, especially when we are discussing high ranking officials. Ultimately, we are a nation for the people and by the people. Thus, we decide whether we place age limitations on our elected officials or not by going to the polls.
Earlier this year, Morgan Lewis and Compliance Week conducted a survey on anti-bribery and corruption efforts by compliance professionals. The results of the survey showed that there are not enough resources to combat recent trends in bribery. Recently, there have been multiple million-dollar settlements regarding bribery claims.
The Internal Revenue Service (I.R.S.) issued a press release on September 8, 2023, detailing how the agency plans to use at least part of the $80 million dollar allocation it received from the Inflation Reduction Act last year. I.R.S. Commissioner Danny Werfel plans to use the funds to make compliance enforcement efforts and tax evasion identification more effective and efficient. How does he plan to do this? The overwhelmed and perhaps overworked agency will be using artificial intelligence (AI) programs and features to expedite and assist with redundant processes as well as to audit parties that are too complicated or large for the I.R.S.’s current capabilities.
Recent instances of politicians experiencing medical episodes in the public eye have sparked discussions regarding age limits for politicians. However, a parallel conversation is emerging about the healthcare professionals responsible for our well-being. About four years ago, a small number of health care institutions began implementing various forms of neuropsychological testing policies for older physicians. Since then – over the past few years – this practice has continued to grow and become increasingly controversial. The ongoing debate centers around determining the appropriate age to commence testing for physicians, the specific parameters to test for, and the ethics of mandating such testing. These questions remain subjects of ongoing debate, yet considering the rising demographic of physicians over the age of 60, there is a growing argument for integrating some form of neuropsychological examination.